348 results match your criteria Dyshidrotic Eczema

[Palmoplantar dermatoses in children].

Hautarzt 2021 Mar 12;72(3):215-224. Epub 2021 Feb 12.

Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München LMU, Frauenlobstr. 9-11, 80337, München, Deutschland.

Dermatoses of the hands and feet cover a wide range of skin diseases that can occur in children and adolescents and are a frequent question in dermatological practice. Our synopsis of the most important differential diagnoses and their treatment is intended to provide better orientation for daily practice. A precise and detailed history is essential to establish a diagnosis, followed by clinical examination and specific examination methods. Read More

View Article and Full-Text PDF

Dyshidrotic Eczema: A Common Cause of Palmar Dermatitis.

Cureus 2020 Oct 7;12(10):e10839. Epub 2020 Oct 7.

Internal Medicine, University of Connecticut School of Medicine, Farmington, USA.

Dyshidrotic eczema (DE) or acute palmoplantar eczema is a common cause of hand and foot dermatitis in adults. It is a recurrent vesicular eruption affecting the soles, palms, or both. It is very pruriginous and generally appears suddenly. Read More

View Article and Full-Text PDF
October 2020

Ayurvedic visha hara (antitoxic) chikitsa in recurrent dyshidrotic eczema skin disease: A case report.

J Ayurveda Integr Med 2021 Jan-Mar;12(1):156-160. Epub 2020 Aug 27.

Department of Agada Tantra Evumvyavhara Ayurveda, Sushrutha Ayurvedic Medical College & Hospital, Bengaluru, karnataka, 560105, India.

Dyshidrotic eczema is a chronic, enigmatic condition that usually affects the hands and feet that probably accounts for about 5%-20% of hand eczemas. In Ayurveda various skin manifestation are mentioned under different chapter & context like kushtha, visarpa, kshudra kushtha, vidradi, krimi roga, keeta visha (insect bite), Garavisha &Dooshi visha (latent toxicity).Visphota variety of kushtha is characterized by pustules which are either white or reddish in appearance. Read More

View Article and Full-Text PDF

Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.

Dermatol Ther 2020 11 3;33(6):e14147. Epub 2020 Sep 3.

Department of Dermatology, Medical Faculty, Istanbul Medeniyet University, Göztepe Research and Training Hospital, Istanbul, Turkey.

Intravenous immunoglobulin (IVIg) is increasingly used for the treatment of inflammatory and autoimmune diseases. Although skin reactions to IVIg therapy are usually minor, rare, and not life-threatening, dermatologists need to recognize the nature of these adverse reactions. We describe a 33-year-old man suffering from demyelinating polyneuropathy who developed dyshidrotic eczema on the palms and flaky grayish-white scales on an erythematous base on his face after the administration of IVIg. Read More

View Article and Full-Text PDF
November 2020

Secukinumab-induced pompholyx in a psoriasis patient.

Gerhard Eichhoff

Dermatol Online J 2020 Apr 15;26(4). Epub 2020 Apr 15.

Dermatology Service Capital and Coast District Health Board, Wellington.

With a prevalence of up to 20%, eczematous lesions are the most common skin adverse events of tumor necrosis factor alpha inhibitors. Eczematous lesions triggered by more modern biologics such as the IL17A antagonist secukinumab have been rarely reported. Herein, a case of secukinumab-induced pompholyx in a psoriasis patient is presented. Read More

View Article and Full-Text PDF

Successful treatment of dyshidrotic palmoplantar eczema with ultraviolet A1 light-emitting diodes.

J Dermatol 2020 Aug 22;47(8):922-923. Epub 2020 May 22.

Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article and Full-Text PDF

Pyogenic Flexor Tenosynovitis as a Rare Complication of Dyshidrotic Eczema.

Clin Pract Cases Emerg Med 2020 May 27;4(2):174-177. Epub 2020 Mar 27.

Mount Sinai Medical Center, Department of Emergency Medicine, Miami Beach, Florida.

Introduction: Pyogenic flexor tenosynovitis is an unusual complication of dyshidrotic eczema. The diagnosis has traditionally been made by Kanavel's signs. Point-of-care ultrasound can be a useful adjunct in the diagnosis of this surgical emergency. Read More

View Article and Full-Text PDF

Successful treatment of recalcitrant dyshidrotic eczema with oxybutynin.

Int J Dermatol 2020 Aug 9;59(8):1010-1012. Epub 2020 May 9.

Dermatology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.

View Article and Full-Text PDF

Botulinum toxin type A in chronic non-dyshidrotic palmar eczema: A side-by-side comparative study.

J Dermatol 2020 Jun 14;47(6):601-608. Epub 2020 Apr 14.

Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

New indications are being reported for intradermal botulinum toxin type A (BTX-A) owing to its anti-inflammatory and antipruritic actions. Its successful use for dyshidrotic hand eczema and lichen simplex has been reported in a few cases, while its utility in dry palmar eczema not associated with hyperhidrosis has not yet been investigated. The aim of this study was the assessment of the additive efficacy and tolerability of BTX-A in chronic dry palmar eczema. Read More

View Article and Full-Text PDF

as an Unusual Agent Causing Palmoplantar Eczema: An Emerging Pathogen.

Eur J Case Rep Intern Med 2020 10;7(2):001458. Epub 2020 Feb 10.

Dermatology Department, University Hospital of Heraklion, Crete, Greece.

Introduction: , described as a new species over 20 years ago, has been isolated mainly from the external ear canal and middle ear fluid. Here, we report the first case of palmoplantar eczema related to

Case Presentation: Here, we report the first case of palmoplantar eczema in a 74-year-old female related to

Conclusions: The question as to whether is a potential pathogen in cases of dyshidrotic eczema is still open, but this could be better elucidated if corynebacteria were speciated more often.

Learning Points: The coryneform bacteria and auris were recently detected for the first time in the middle ear of patients with acute otitis media and chronic otitis media. Read More

View Article and Full-Text PDF
February 2020

Dyshidrotic eczema in two patients on secukinumab for plaque psoriasis: A case report.

SAGE Open Med Case Rep 2020 10;8:2050313X20904561. Epub 2020 Feb 10.

Division of Dermatology, The Ottawa Hospital, Ottawa, ON, Canada.

Secukinumab was the first fully human anti-interleukin-17a monoclonal antibody and successfully treated moderate-severe psoriasis. These new, targeted, medications are becoming more ubiquitous, but long-term side effects are not fully known. Post-market surveillance is crucial to identify delayed adverse events, analogous to the paradoxical development of pustular psoriasis in a subset of patients treated with the anti-tumor necrosis factor-alpha class drugs. Read More

View Article and Full-Text PDF
February 2020

Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients.

J Am Acad Dermatol 2020 05 8;82(5):1251-1252. Epub 2020 Jan 8.

Department of Dermatology, University of Connecticut, Farmington, Connecticut. Electronic address:

View Article and Full-Text PDF

Spongiform pemphigoid: A case series of an uncommon histopathologic pattern.

J Cutan Pathol 2020 Apr 23;47(4):339-345. Epub 2019 Dec 23.

Department of Medicine, MacKay Medical College, New Taipei City, Taiwan.

Introduction: Bullous pemphigoid is an autoimmune bullous disease characterized by subepidermal separation. We encountered cases of bullous pemphigoid confirmed by direct immunofluorescence study but demonstrating spongiotic dermatitis without subepidermal clefting. Many of them occurred in volar sites, mimicking dyshidrotic dermatitis. Read More

View Article and Full-Text PDF

Trend of relevant contact allergens of the feet in Spain over a period of 10 years.

Contact Dermatitis 2020 Apr 28;82(4):211-217. Epub 2019 Nov 28.

Dermatology Department, Hospital Universitario de La Princesa, Madrid, Spain.

Introduction: Allergic contact dermatitis (ACD) of the feet accounts for approximately 10% of all patch tested patients.

Objective: To study the clinical profile of patients with feet dermatitis and relevant contact allergens in Spain over a 10-year period.

Methods: Retrospective observational study of patients with suspected ACD from the GEIDAC (Spanish Research Group on Contact Dermatitis and Cutaneous Allergy) baseline series from eight hospitals in Spain between 2004 and 2014. Read More

View Article and Full-Text PDF

Successful treatment of recalcitrant dyshidrotic eczema with dupilumab in a child.

J Dtsch Dermatol Ges 2019 11 14;17(11):1165-1167. Epub 2019 Oct 14.

Department of Dermatology and Allergy Biederstein, University hospital of the Technical University Munich (TUM), Munich, Germany.

View Article and Full-Text PDF
November 2019

Pompholyx vesicles contain small clusters of cells with high levels of hyaluronate resembling the pustulovesicles of palmoplantar pustulosis.

Br J Dermatol 2019 12 9;181(6):1325-1327. Epub 2019 Oct 9.

Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan.

View Article and Full-Text PDF
December 2019

Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect.

Clin Cosmet Investig Dermatol 2019 10;12:223-228. Epub 2019 Apr 10.

Department of Pharmacology, Faculty of Medicine, Udayana University, Bali, Indonesia.

: Botulinum toxin (Botox) consists of 7 types of neurotoxins; however, only toxins A and B are used clinically. Botox A is used for several disorders in the field of medicine, particularly in dermatology, for cosmetic purposes. It is produced by the bacterium and can be used as a treatment to reduce the appearance of wrinkles in the upper areas of the face, elevate the eyebrows and treat problems such as hyperhidrosis, lichen simplex, pompholyx (dyshidrotic eczema) and acne vulgaris. Read More

View Article and Full-Text PDF

Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx.

J Dermatol 2019 May 28;46(5):399-408. Epub 2019 Mar 28.

Department of Dermatology, Ehime University Graduate School of Medicine, Toon, Japan.

Palmoplantar pustulosis (PPP) and pompholyx are both chronic and relapsing diseases occurring on the palms and soles. Although these two diseases have been considered completely different from each other, it is sometimes very difficult even for dermatologists to differentiate them from each other because of their similarities in clinical presentation. In this study, we aimed to analyze the histopathological features of PPP and pompholyx and find out "clues" to differentiate between PPP and pompholyx by their histopathological features. Read More

View Article and Full-Text PDF

Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.

BMJ Case Rep 2019 Mar 21;12(3). Epub 2019 Mar 21.

Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.

View Article and Full-Text PDF

A Case of Complete Resolution of Severe Plantar Dyshidrotic Eczema With Dupilumab

J Drugs Dermatol 2019 Feb;18(2):211-212

A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years that impaired her ability to walk. Read More

View Article and Full-Text PDF
February 2019

[Genetic-morphological peculiarities of response to standard therapy in patients with dyshidrotic eczema of palms and soles].

Wiad Lek 2018;71(9):1707-1713

Department of Pathological and Topographic Anatomy of Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.

Objective: Introduction: Dyshidrotic eczema of palms and soles (DEPS) is an inflammatory skin disorder that has a multifactorial nature and is characterized by the development of vesical elements with the histological picture of spongiosis and development of intraepidermal vesicles. The aim: Establishment of the features of pathomorphological changes of the epidermis and dermis in patients with manifestations of dyshidrotic lesions of palms and soles with different genotypic variants of the C646G of the NR3C1 gene before treatment based on the study of skin biopsies taking into account the response to standard therapy.

Patients And Methods: Materials and methods: In 57 patients with dyshidrotic lesions, a pathomorphological and immunohistochemical examination of biopsy specimens from a lesion focus of the skin were carried out and a genetic examination was carried out to determine the polymorphic variant C646G of the NR3C1 gene. Read More

View Article and Full-Text PDF

Complete Resolution of Infection with Clarithromycin and Ethambutol: A Case Report and a Review of the Literature.

J Clin Aesthet Dermatol 2018 Dec 1;11(12):48-51. Epub 2018 Dec 1.

Ms. Krooks, Dr. Weatherall, and Dr. Markowitz are with the Florida Atlantic University Charles E. Schmidt College of Medicine in Boca Raton, Florida.

A 70-year-old, immunocompetent male presented with mildly painful and pruritic erythematous patches and vesicles on the right dorsal aspect of the distal middle finger present for four weeks. Other skin lesions or systemic symptoms were notably absent. The patient failed to respond to valacyclovir, topical triamcinolone acetonide ointment, trimethoprim-sulfamethoxazole, and cephalexin for presumptive diagnoses of recurrent herpetic whitlow, dyshidrotic eczema, and blistering distal dactylitis, respectively. Read More

View Article and Full-Text PDF
December 2018

Pruritic Rash on the Hands and Feet.

Am Fam Physician 2018 12;98(11):685-686

St. Luke's Family Medicine Residency/Sacred Heart Campus, Allentown, PA, USA.

View Article and Full-Text PDF
December 2018

Erythroderma: A Rare Complication of Dyshidrotic Eczema.

Cureus 2018 Jul 19;10(7):e3005. Epub 2018 Jul 19.

Department of Dermatology, Creighton University School of Medicine, Omaha, USA.

A 47-year-old man with a history of dyshidrotic eczema presented to the emergency department with diffuse erythema, chills and pruritus of three weeks' duration. The patient had received two injections of methotrexate in the preceding two weeks, both of which had failed to improve his whole-body erythema and pruritus. In the emergency department, the patient was evaluated for infection and admitted for the dermatology consultation. Read More

View Article and Full-Text PDF

Dupilumab in the Treatment of Dyshidrosis: A Report of Two Cases.

J Drugs Dermatol 2018 Mar;17(3):355-356

Dupilumab (Dupixent, Regeneron Pharmaceuticals and Sanofi Genzyme) is a novel biologic medication recently approved by the FDA for the treatment of moderate-to-severe atopic dermatitis in adults who have not achieved adequate control with topical medications. Dyshidrotic eczema is a distinct entity, often considered on the spectrum of atopic dermatitis, that primarily effects the palms and soles; it is often associated with considerable morbidity yet is frequently challenging to treat. We report two cases of recalcitrant dyshidrotic eczema treated successfully with dupilumab at standard dosing. Read More

View Article and Full-Text PDF

Dyshidrotic Bullous Pemphigoid: Case Report and Review of Literature.

J Cutan Med Surg 2018 Nov/Dec;22(6):614-617. Epub 2018 Mar 5.

1 Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.

Background: Dyshidrotic pemphigoid (DP) is a rare variant of bullous pemphigoid (BP) that affects the hands and feet and may resemble an acute vesicular eczema. While it can remain confined to hands and feet, spread that involves the entire body is described. BP and DP are associated with autoantibodies directed against hemidesmosomal proteins BP180 (collagen XVII) and BP230 (dystonin), which are transmembrane and intracellular proteins in the basement membrane zone, respectively. Read More

View Article and Full-Text PDF
January 2019

Impetiginized Dyshidrotic Eczema.

Open Access Maced J Med Sci 2017 Jul 19;5(4):539-540. Epub 2017 Jul 19.

Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden, Germany.

A 16 years old female patient, affected by atopic dermatitis and rhinoconjunctivitis allergica since childhood, requested a dermatologic consultation for lesions which had appeared after 3 months of local treatment with clobethasole propionate. The histological analysis confirmed the diagnosis of dyshidrotic eczema and the microbiological smears demonstrated a significant infection with . The risk of developing corticosteroids' side-effects depends on the potency of the product, extended period of use and the volume of product applied. Read More

View Article and Full-Text PDF

Dermatitis of the Foot: Epidemiologic and Clinical Features in 389 Children.

Pediatr Dermatol 2017 Sep 21;34(5):535-539. Epub 2017 Jul 21.

Dermatology Department, Valencia University General Hospital, Valencia, Spain.

Background/objectives: Footwear dermatitis is a form of contact dermatitis resulting from exposure to shoes. There have been only small studies regarding foot contact dermatitis in children. The present study was undertaken to define the prevalence and epidemiologic and clinical features of shoe dermatitis in children. Read More

View Article and Full-Text PDF
September 2017